Medical News

RSS

AtriCure first quarter revenue increases 11.8% to $17.5 million

AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, today announced financial results for the first quarter of 2012.

3 May 2012

Study confirms that COX-2 inhibitors predispose people to cardiovascular disease

After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.

3 May 2012

Maternal intake of choline could reduce risk of hypertension, diabetes in children

Pregnant women may have added incentive to bulk up on broccoli and eggs now that a Cornell University study has found increased maternal intake of the nutrient choline could decrease their children's chances of developing hypertension and diabetes later in life.

3 May 2012

FDA clears Angioslide’s new 3X100mm PROTEUS device

Angioslide Ltd. a provider of Embolic Capture Angioplasty solutions, today announced that it has received FDA 510(K) clearance for its new 3X100mm PROTEUS device for treating Peripheral Artery Disease in below the knee (BTK) vasculature.

3 May 2012

ArthroCare first quarter total revenue increases 5.6% to $92.9 million

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2012.

3 May 2012

Roundup: Mass. health cost control bill could save $8B to $34B; Md. weighs hospital rate freeze; Iowa Senate passes a fix for HIV insurance program

As Massachusetts' state legislators put the finishing touches on a major health care cost-control bill, there is still one big question: How much could it save? A recent report claims employers and employees could see between $8 billion and $34.5 billion in savings over nine years.

3 May 2012

Not enough 14 year old girls are getting adequate exercise at school: Report

According to new research into sports and physical education (PE) at school by the Women's Sport & Fitness Foundation (WSF) suggests that the embarrassment of PE classes can put young women off exercise for the rest of their life.

2 May 2012

Flu paper publication amidst threats of bioterrorism raises need for better rules of censorship

According to the editor of the scientific journal Nature, Dr Philip Campbell current procedures to assess and censor medical research potentially of use to terrorists need to be improved. He was speaking about the recent controversy regarding the bird flu virus H5N1 study. The study was initially stopped from publication fearing risk of bioterrorism. He was speaking to BBC News.

2 May 2012

Contemporary form of swaddling recommended to prevent dysplasia in infants

While tight swaddling may provide a newborn infant with a feeling of warmth and security, studies have found that regularly wrapping a child too tightly in a blanket or cloth may lead to an abnormal development of the hip joint, causing the ball of the hip to dislocate from the hip socket.

2 May 2012

Women who spend long hours sitting are at increased risk for diabetes

A new study finds women who spend four to seven hours a day sitting are more likely to show early signs of type 2 diabetes, but researchers have found no such link in men. During National Women's Health Week and beyond, the Academy of Nutrition and Dietetics encourages all women to take steps to increase physical activity and decrease their risk of developing diabetes.

2 May 2012

Arena's first quarter net loss decreases to $29.4 million

Arena Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2012, and reviewed recent developments.

2 May 2012

Tips to help homeowners tick-proof their yards

For more than 250,000 Americans, the bite of a deer tick meant the start of a life changing disease. With record warm temperatures and the start of May's National Lyme Disease Awareness Month, Mosquito Squad is on watch and has six tips to help homeowners tick-proof their yards.

2 May 2012

FDA approval of TDF/FTC as PrEP for HIV infection receives support

In public comments submitted this week, a group of 14 leading HIV/AIDS and health organizations stated their support for Food and Drug Administration (FDA) approval of emtricitabine/ tenofovir disoproxil fumarate (TDF/FTC or Truvada) as pre-exposure prophylaxis (PrEP) to prevent HIV infection in adult men and women.

2 May 2012

First anniversary of Capital BlueCross' Accountable Care Arrangement programs

Today marks the one-year anniversary of Capital BlueCross' launch of two Accountable Care Arrangements (ACA). Preliminary results demonstrate that this innovative care delivery model is improving care coordination, lowering the medical cost trend, and improving the member's management of chronic conditions and overall satisfaction with care.

2 May 2012

Misleading information about breast brachytherapy

One of the leading experts on radiation therapy for breast cancer says a new study in JAMA -- about breast cancer treatment - has misleading information and may unnecessarily deter women from getting breast brachytherapy, a safe and effective treatment.

2 May 2012

Health Care REIT completes acquisition with Chartwell Seniors Housing REIT

Health Care REIT, Inc. announced today that it has completed the acquisition with Chartwell Seniors Housing REIT of 42 seniors housing and care communities in attractive Canadian markets, which was previously announced on February 15, 2012.

2 May 2012

Kindred Healthcare first quarter consolidated revenues increase 33% to $1.6 billion

Kindred Healthcare, Inc. today announced its operating results for the first quarter ended March 31, 2012. The Company's consolidated financial statements include the operating results of RehabCare Group, Inc. since the closing of the acquisition on June 1, 2011.

2 May 2012

German BfArM grants Moberg Derma approval to initiate Limtop phase II actinic keratosis trial

The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.

2 May 2012

Levetiracetam to be tested for seizure management in malaria endemic regions

Michigan State University researchers, with the help of a groundbreaking medical device, are starting a clinical trial in Africa they hope will provide relief for the hundreds of thousands of children who survive cerebral malaria but are left stricken with epilepsy or other neurologic disorders.

2 May 2012

Optimum blood vitamin D levels to reduce risk of major medical events

In testing older patients' blood vitamin D levels, there's uncertainty about where the dividing line falls between enough and not enough. The threshold amount has become controversial as several scientific societies set different targets.

2 May 2012